CHEMLOK 250

Hazard statements (CLP)

H226, H315, H317, H319, H334, H335, H336, H341, H350, H360, H362, H370, H372, H411

Code

Statements

H226

Flammable liquid and vapour

SECTION 2: Hazards identification

GHS CLASSIFICATION Flammable liquids Category 3 Skin corrosion/irritation Category 2 Serious eye damage/eye irritation Category 2A Skin sensitization Category 1A Respiratory sensitization Category 1 Germ cell mutagenicity Category 2 Carcinogenicity Category 1A Reproductive toxicity Category 1A Specific target organ systemic toxicity (single exposure) Category 3 Specific target organ systemic toxicity (single exposure) Category 1 Central nervous system, Kidney, Liver, Respiratory system Specific target organ systemic toxicity (single exposure) Category 2 blood system Specific target organ systemic toxicity (single exposure) Category 3 Specific target organ systemic toxicity (repeated exposure) Category 1 Nervous system, Respiratory system, Central nervous system, Liver Specific target organ systemic toxicity (repeated exposure) Category 2 Ears, blood system Hazardous to the aquatic environment - acute hazard Category 2 Hazardous to the aquatic environment - chronic hazard Category 2

Signal word

DANGER

Hazard statements

Flammable liquid and vapor. Causes skin irritation. Causes serious eye irritation. May cause an allergic skin reaction. May cause allergy or asthma symptoms or breathing difficulties if inhaled. Suspected of causing genetic defects. May cause cancer. May damage fertility or the unborn child. May cause harm to breast-fed children. 300000001219 May cause drowsiness or dizziness. Causes damage to organs.(Central nervous system, Kidney, Liver, Respiratory system) May cause damage to organs.(blood system) May cause respiratory irritation. Causes damage to organs through prolonged or repeated exposure.(Nervous system, Respiratory system, Central nervous system, Liver) May cause damage to organs through prolonged or repeated exposure.(Ears, blood system) Toxic to aquatic life. Toxic to aquatic life with long lasting effects.

Prevention

Keep away from heat/sparks/open flames/hot surfaces. - No smoking. Ground/Bond container and receiving equipment. Use explosion-proof electrical/ventilating/lighting equipment. Use only non-sparking tools. Take precautionary measures against static discharge. Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Wear protective gloves/protective clothing/eye protection/face protection. Use personal protective equipment as required. In case of inadequate ventilation wear respiratory protection. Do not breathe dust/fume/gas/mist/vapors/spray. Wash thoroughly after handling. Do not eat, drink or smoke when using this product. Use only outdoors or in a well-ventilated area. Contaminated work clothing should not be allowed out of the workplace. Avoid release to the environment.

Response

In case of fire: refer to section 5 of SDS for extinguishing media. Call a POISON CENTER or doctor/physician if you feel unwell. IF exposed: Call a POISON CENTER or doctor/physician. Specific treatment (see supplemental first aid instructions on this label). IF INHALED: Remove to fresh air and keep at rest in a position comfortable for breathing. If experiencing respiratory symptoms: Call a POISON CENTER or doctor/physician. IF ON SKIN (or hair): Remove/Take off immediately all contaminated clothing. Rinse skin with water/shower. If skin irritation or rash occurs: Get medical advice/attention. IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Collect spillage.

Storage

Store in a well-ventilated place. Keep cool. Store in a well-ventilated place. Keep container tightly closed. Store locked up.

Disposal

Dispose of contents/container in accordance with waste/disposal laws and regulations of your country or particular locality.

2.3 Other hazards

This product contains component(s) which have the following warnings; however based on the GHS classification criteria of your country or locale, the product mixture may be outside the respective category(s). Acute: Vapor harmful; may affect the brain or nervous system causing dizziness, headache or nausea. In elevated- temperature applications, product may release vapors that may produce cyanosis in the absence of sufficient ventilation or adequate respiratory protection. Possible irritation of the respiratory system can occur causing a variety of symptoms such as dryness of the throat, tightness of the chest, and shortness of breath. May cause central nervous system depression characterized by the following progressive steps: headache, dizziness, staggering gait, confusion, unconsciousness or coma. Allergic conditions can occur in certain individuals with high sensitivity to isocyanates; this may result in asthma-like symptoms. Animal tests have indicated that respiratory sensitization can result from skin contact with certain isocyanates. May cause lung damage.May be harmful if swallowed. Ingestion is not an expected route of entry in industrial or commercial uses. Chronic: May cause long-term lung damage. May affect the gastrointestinal system. Overexposure to lead in this product can damage the nervous, urinary, gastrointestinal, blood, blood-forming, and reproductive systems. Lead and lead compounds have been classified by IARC as probable human carcinogens (Group 2A), and by NTP as reasonably anticipated human carcinogens. The nitrogen substituted aromatic in this product gave positive results for mutagenicity in an Ames Assay study while two other mutagenicity studies proved negative. Trichloroethylene has been classified by IARC as a human carcinogen (Group 1) and by NTP as a reasonably anticipated human carcinogen. Ethylbenzene has been classified by IARC as a possible human carcinogen (Group 2B) and reported by NTP to show clear evidence for carcinogenicity in animals. IARC has designated carbon black as Group 2B - inadequate evidence for carcinogenicity in humans, but sufficient evidence in experimental animals. In 2006 IARC reaffirmed its 1995 finding that there is "inadequate evidence" from human health studies to assess whether carbon black causes cancer in humans. Further, epidemiological evidence from well-conducted investigations has shown no causative link between carbon black exposure and the risk of malignant or non-malignant respiratory disease in humans. 1,2 butylene oxide has been classified by IARC as a possible human carcinogen (Group 2B) and reported by NTP to show clear evidence for carcinogenicity in animals.

2.1 Classification of the substance or mixture

Flammable liquids Category 3 Skin corrosion/irritation Category 2 Serious eye damage/eye irritation Category 2A Skin sensitization Category 1A Respiratory sensitization Category 1 Germ cell mutagenicity Category 2 Carcinogenicity Category 1A Reproductive toxicity Category 1A Specific target organ systemic toxicity (single exposure) Category 3 Specific target organ systemic toxicity (single exposure) Category 1 Central nervous system, Kidney, Liver, Respiratory system Specific target organ systemic toxicity (single exposure) Category 2 blood system Specific target organ systemic toxicity (single exposure) Category 3 Specific target organ systemic toxicity (repeated exposure) Category 1 Nervous system, Respiratory system, Central nervous system, Liver Specific target organ systemic toxicity (repeated exposure) Category 2 Ears, blood system Hazardous to the aquatic environment - acute hazard Category 2 Hazardous to the aquatic environment - chronic hazard Category 2